Trials / Sponsors / Nirmish Shah
Nirmish Shah
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | AB1 in Adult Patients with Sickle Cell Disease (SCD) Sickle Cell Disease | Phase 1 / Phase 2 | 2022-12-05 |
| Terminated | Apixaban in Patients With Sickle Cell Disease Vaso-occlusive Crisis, Reduction in Hospitalizations, Sickle Cell Disease | Phase 3 | 2015-01-01 |